Octapharma AG - Company Profile
Powered by 
All the sales intelligence you need on Octapharma AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Octapharma AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Octapharma AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Octapharma AG (Octapharma) develops, produces, and sells high-quality plasma derivatives for the treatment of life-threatening diseases such as hemophilia. Market position in the human protein market, improved operational performance, and focus on research and development are its major strengths, even as private ownership could be a cause for concern. Clinical Development in Perioperative Critical Care, regulatory approval, and business expansion initiatives can have an adverse effect on Octapharma's business, operating results and financial position. However, business expansion initiatives, market potential for Hemophilia, and growth initiatives could present growth opportunities for the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer